Skip to main content

Table 1 Omparison of clinical and laboratory characteristics of patients with and without pulmonary hypertension

From: Renal transplant improves pulmonary hypertension in patients with end stage renal diseaseIl trapianto renale riduce l’ipertensione polmonare nei pazienti con grave insufficienza renale

Clinical characteristics

Patients with PH (n = 85)

Patients without PH (n = 415)

P

Age (y)

31.7 ± 10.6

31.5 ± 10.1

0.8

Sex (n)

62 M, 23 F

305 M, 110 F

0.8

Duration of dialysis therapy (months)

50.8

38.5

0.008

COPD (%)

2.4

0.7

0.2

Tobacco smoking (%)

29.4

25.8

0.5

Diabetes mellitus (%)

3.5

3.4

1.0

Hypertension (%)

69.4

61.2

0.1

Echocardiographic Data

   

   IVS (cm)

1.49 ± 1.38

1.29 ± 0.68

0.03

   PW (cm)

1.48 ± 1.28

1.30 ± 0.81

0.09

   LV, diastole (cm)

4.9 ± 0.5

4.7 ± 2.0

0.3

   LV, systole (cm)

3.2 ± 0.5

3.1 ± 0.5

0.8

   Right ventricle (cm)

3.3 ± 0.5

3.2 ± 0.4

0.8

   Left atrium (cm)

4.0 ± 0.7

3.5 ± 0.6

< 0.0001

   Right atrium (cm)

3.7 ± 0.5

3.3 ± 0.4

< 0.0001

   Diastolic dysfunction (%)

18.8

21.4

0.6

   Systolic dysfunction (%)

22.4

13.5

0.04

   LV Ejection fraction (%)

49.7 ± 7.9

52.3 ± 6.9

0.002

   Left ventricular hypertrophy (%)

78.8

59.8

0.001

  1. Data are expressed as mean ± SD, or frequency counts (percentages), as appropriate.
  2. Definition of abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; COPD, chronic obstructive pulmonary disease; IVS, interventricular septum; LV, left ventricle; PH, pulmonary hypertension; PW, posterior wall; SD, standard deviation.